Pinnacle Associates’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $68.6K | Hold |
|
|||||
|
2025
Q2 | $48.1K | Sell |
|
|||||
|
2025
Q1 | $25K | Sell |
|
|||||
|
2024
Q4 | $1.05M | Sell |
|
|||||
|
2024
Q3 | $2.65M | Buy |
|
|||||
|
2024
Q2 | $2.88M | Sell |
|
|||||
|
2024
Q1 | $4.19M | Buy |
|
|||||
|
2023
Q4 | $2.65M | Sell |
|
|||||
|
2023
Q3 | $2.09M | Sell |
|
|||||
|
2023
Q2 | $4.57M | Buy |
|
|||||
|
2023
Q1 | $4.71M | Buy |
|
|||||
|
2022
Q4 | $3.69M | Sell |
|
|||||
|
2022
Q3 | $4.88M | Sell |
|
|||||
|
2022
Q2 | $3.88M | Sell |
|
|||||
|
2022
Q1 | $4.38M | Sell |
|
|||||
|
2021
Q4 | $8.38M | Buy |
|
|||||
|
2021
Q3 | $10.1M | Sell |
|
|||||
|
2021
Q2 | $10.1M | Buy |
|
|||||
|
2021
Q1 | $12.7M | Buy |
|
|||||
|
2020
Q4 | $6.33M | Buy |
|
|||||
|
2020
Q3 | $500K | Sell |
|
|||||
|
2020
Q2 | $715K | Buy |
|
|||||
|
2020
Q1 | $695K | Sell |
|
|||||
|
2019
Q4 | $1.66M | Sell |
|
|||||
|
2019
Q3 | $1.42M | Sell |
|
|||||
|
2019
Q2 | $3.21M | Sell |
|
|||||
|
2019
Q1 | $3.06M | Buy |
|
|||||
|
2018
Q4 | $3.59M | Sell |
|
|||||
|
2018
Q3 | $6.17M | Sell |
|
|||||
|
2018
Q2 | $8.1M | Sell |
|
|||||
|
2018
Q1 | $6.78M | Sell |
|
|||||
|
2017
Q4 | $8.44M | Sell |
|
|||||
|
2017
Q3 | $11M | Buy |
|
|||||
|
2017
Q2 | $11.8M | Buy |
|